Pennant Group, Inc.
PNTG- Exchange
- Nasdaq
- Industry
- Services-Health Services
- SEC CIK
- 0001766400
No open-market purchases or sales by Pennant Group, Inc. insiders were filed in the last 90 days; 204 institutions reported holding it in 13F filings for Q2 2026, worth $1.17B in total; no superinvestor holds it.
- Currency
- USD
- Source
- SEC XBRL data (10-K, 10-Q, 20-F, 40-F)
- Updated
- Nov 5, 2026, 12:21 AM ET
Revenue flow, FY2025
Where the revenue went in FY2025, from the income statement below. Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue; hover over a band or a bar for the exact amount.
Income statement
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Feb 25, 2026 | Feb 27, 2025 | Feb 28, 2024 | Feb 23, 2023 | Feb 28, 2022 |
| Revenue | $947.7M | $695.2M | $544.9M | $473.2M | $439.7M |
| Selling, general and administrative | $71.1M | $50.2M | $36.7M | – | – |
| Operating income | $51.9M | $38.1M | $25.2M | $12.7M | $4.70M |
| Interest expense | – | – | $5.92M | $3.82M | $1.94M |
| Income tax | $11.9M | $7.03M | $5.67M | $1.65M | $582.0K |
| Net income | $29.6M | $22.6M | $13.4M | $6.64M | $2.70M |
| EPS, basic | $0.86 | $0.72 | $0.45 | $0.23 | $0.09 |
| EPS, diluted | $0.84 | $0.70 | $0.44 | $0.22 | $0.09 |
| Weighted shares, basic | 34.6M | 31.2M | 29.9M | 29.1M | 28.4M |
| Weighted shares, diluted | 35.3M | 32.0M | 30.2M | 30.2M | 30.6M |
| Margins and growth | |||||
| Operating margin | 5.5% | 5.5% | 4.6% | 2.7% | 1.1% |
| Net margin | 3.1% | 3.2% | 2.5% | 1.4% | 0.6% |
| Revenue growth, year over year | +36.3% | +27.6% | +15.1% | +7.6% | +12.5% |
| Net income growth, year over year | +31.1% | +68.6% | +101.4% | +146.4% | −82.9% |
Balance sheet
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Feb 25, 2026 | Feb 27, 2025 | Feb 28, 2024 | Feb 23, 2023 | Feb 28, 2022 |
| Cash and equivalents | $17.0M | $24.2M | $6.06M | $2.08M | $5.19M |
| Accounts receivable | $123.1M | $81.3M | $61.1M | $53.4M | $53.9M |
| Total current assets | $167.4M | $122.9M | $80.1M | $73.8M | $75.8M |
| Property, plant and equipment | $61.0M | $43.3M | $28.6M | $26.6M | $16.8M |
| Goodwill | $237.2M | $129.1M | $91.0M | $79.5M | $74.3M |
| Total assets | $968.2M | $679.5M | $539.7M | $512.1M | $530.3M |
| Accounts payable | $25.2M | $18.7M | $10.8M | $13.6M | $10.6M |
| Short-term debt | $5.00M | – | – | – | – |
| Total current liabilities | $147.3M | $101.7M | $71.5M | $70.2M | $71.6M |
| Long-term debt | $168.8M | $0 | $63.9M | $62.9M | $51.4M |
| Total liabilities | $593.9M | $367.6M | $394.2M | $386.5M | $416.1M |
| Shareholders' equity | $374.3M | $312.0M | $145.5M | $125.7M | $114.2M |
Cash flow statement
Each column is one fiscal year, newest first. Free cash flow is operating cash flow minus capital expenditures.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Feb 25, 2026 | Feb 27, 2025 | Feb 28, 2024 | Feb 23, 2023 | Feb 28, 2022 |
| Operating cash flow | $48.3M | $39.3M | $33.1M | $9.04M | -$18.2M |
| Capital expenditures | $12.0M | $8.99M | $8.11M | $14.2M | $6.30M |
| Free cash flow | $36.3M | $30.3M | $25.0M | -$5.13M | -$24.5M |
| Depreciation and amortization | $8.54M | $6.12M | $5.13M | $4.90M | $4.78M |
| Stock-based compensation | $8.94M | $7.78M | $5.37M | $3.09M | $10.0M |
| Dividends paid | – | – | – | – | $0 |
| Share buybacks | – | – | – | $0 | $0 |
| Investing cash flow | -$228.0M | -$70.7M | -$30.2M | -$24.2M | -$20.1M |
| Financing cash flow | $172.5M | $49.6M | $1.11M | $12.1M | $43.5M |
| Net change in cash | -$7.22M | $18.2M | $3.98M | -$3.11M | $5.15M |
| Ratio | |||||
| Stock-based compensation, % of revenue | 0.9% | 1.1% | 1.0% | 0.7% | 2.3% |
Shares outstanding
Common shares outstanding as stated on the cover of each 10-K and 10-Q. The date is the cover date, not the period end; a rising count means dilution.
| Cover date | Shares outstanding | Change in a year | Filing |
|---|---|---|---|
| Nov 2, 2026 | 35.1M | +1.6% | SEC |
| Aug 3, 2026 | 34.9M | +1.1% | SEC |
| May 4, 2026 | 34.8M | +0.9% | SEC |
| Feb 23, 2026 | 34.7M | +0.7% | SEC |
| Nov 3, 2025 | 34.6M | +0.7% | SEC |
| Aug 4, 2025 | 34.6M | +14.4% | SEC |
| May 2, 2025 | 34.5M | +14.7% | SEC |
| Feb 24, 2025 | 34.4M | +14.7% | SEC |
Notes and known gaps
How these numbers are put together, and what they can't tell you.
- Numbers come from the XBRL data in each period's original 10-K, 10-Q, 20-F or 40-F, or its amendment. They are shown as filed: later filings don't restate earlier periods here.
- Reported is the filing date of the first 8-K with Item 2.02 (results of operations) after the period ended, no later than the 10-Q or 10-K and within 120 days. Companies that release results only in the 10-Q, and foreign companies, which use Form 6-K, have none.
Known gaps
- Foreign companies that file Form 20-F or 40-F have annual statements only: their quarterly results are furnished on Form 6-K, which has no XBRL data.
- EPS and share counts are as reported at the time, not adjusted for later stock splits.
- For ADRs, EPS is per ordinary share, not per ADS (one TSMC ADS is five ordinary shares).
- For banks, revenue may be interest income only, depending on how the bank tags its filings; cost of revenue and gross profit are usually blank.
- Companies with several share classes, such as Berkshire Hathaway, may have no EPS and no cover share count.
- Depreciation and amortization is missing for some companies that report it under their own XBRL tags.